Pharming Group N.V. announced that Chief Executive Officer and Executive Director Fabrice Chouraqui has stepped down with immediate effect by mutual agreement with the Board of Directors. The Board has appointed Chief Commercial Officer Leverne Marsh and Chief Financial Officer Kenneth Lynard as Interim Co-CEOs, with Marsh leading patient-focused operations and Lynard leading global corporate functions, and has begun a formal search for a permanent successor. The company said the Board and Chouraqui concluded their views on how to advance Pharming's strategy were not sufficiently aligned following discussions about executing its strategic priorities for the next phase. Chairman Richard Peters said the immediate priority is ensuring continuity across leadership while maintaining focus on executing Pharming's strategy and its commitment to patients, and the company said its strategy, pipeline and commitment to patients remain unchanged. Pharming said it and Chouraqui will not comment further beyond this announcement to support an orderly transition process.
Pharming Group NVCEO Fabrice Chouraqui steps down immediately amid strategic misalignment, creating leadership uncertainty
Shanghai Henlius Biotech Inc